529 related articles for article (PubMed ID: 6427260)
1. Gonadotropin and prolactin pulsations in hyperprolactinemic women before and during bromocriptine therapy.
Klibanski A; Beitins IZ; Merriam GR; McArthur JW; Zervas NT; Ridgway EC
J Clin Endocrinol Metab; 1984 Jun; 58(6):1141-7. PubMed ID: 6427260
[TBL] [Abstract][Full Text] [Related]
2. Abnormal patterns of pulsatile luteinizing hormone secretion in women with hyperprolactinemia and amenorrhea: responses to bromocriptine.
Sauder SE; Frager M; Case GD; Kelch RP; Marshall JC
J Clin Endocrinol Metab; 1984 Nov; 59(5):941-8. PubMed ID: 6434588
[TBL] [Abstract][Full Text] [Related]
3. alpha-Subunit and gonadotropin responses to luteinizing hormone-releasing hormone in hyperprolactinemic women before and after bromocriptine.
Klibanski A; Beitins IZ; Zervas NT; McArthur JW; Ridgway EC
J Clin Endocrinol Metab; 1983 Apr; 56(4):774-80. PubMed ID: 6187760
[TBL] [Abstract][Full Text] [Related]
4. Abnormal LH pulsatility in women with hyperprolactinaemic amenorrhoea normalizes after bromocriptine treatment: deconvolution-based assessment.
Sartorio A; Pizzocaro A; Liberati D; De Nicolao G; Veldhuis JD; Faglia G
Clin Endocrinol (Oxf); 2000 Jun; 52(6):703-12. PubMed ID: 10848874
[TBL] [Abstract][Full Text] [Related]
5. [Correlation of LH and prolactin pulses in normoprolactinemic women with ovulatory disturbances and variation of LH and FSH pulses and secreting capacity by administration of bromocriptine in the same cases].
Kato K; Watanabe R; Ito E; Sakamoto T; Morishima M; Hoshino K; Tanaka M; Tadokoro N
Nihon Sanka Fujinka Gakkai Zasshi; 1986 Dec; 38(12):2241-50. PubMed ID: 3100705
[TBL] [Abstract][Full Text] [Related]
6. [Primary hyperprolactinemic amenorrhea. Report of 4 patients].
Rudolf K; Smid I; Kunkel S; Bazsa-Kassai Z
Zentralbl Gynakol; 1985; 107(14):894-8. PubMed ID: 3929499
[TBL] [Abstract][Full Text] [Related]
7. Effects of a dopamine antagonist on the release of gonadotropin and prolactin in normal women and women with hyperprolactinemic anovulation.
Quigley ME; Judd SJ; Gilliland GB; Yen SS
J Clin Endocrinol Metab; 1979 Apr; 48(4):718-20. PubMed ID: 429515
[TBL] [Abstract][Full Text] [Related]
8. PRL action on E2 ovarian secretion.
Polatti F; Nava C; Brambilla A; Zara C
Clin Exp Obstet Gynecol; 1982; 9(3):160-4. PubMed ID: 6819897
[TBL] [Abstract][Full Text] [Related]
9. Nocturnal melatonin and luteinizing hormone rhythms in women with hyperprolactinemic amenorrhea.
Luboshitzky R; Lavi S; Thuma I; Lavie P
J Pineal Res; 1996 Mar; 20(2):72-8. PubMed ID: 8815190
[TBL] [Abstract][Full Text] [Related]
10. Longitudinal evaluation of the luteal phase and its transition into the follicular phase.
Vermesh M; Kletzky OA
J Clin Endocrinol Metab; 1987 Oct; 65(4):653-8. PubMed ID: 3116029
[TBL] [Abstract][Full Text] [Related]
11. Naloxone increases the frequency of pulsatile luteinizing hormone secretion in women with hyperprolactinemia.
Cook CB; Nippoldt TB; Kletter GB; Kelch RP; Marshall JC
J Clin Endocrinol Metab; 1991 Nov; 73(5):1099-105. PubMed ID: 1939525
[TBL] [Abstract][Full Text] [Related]
12. Catecholamines and pituitary-function. V. Effect of low-dose dopamine infusion on basal and gonadotropin-releasing hormone stimulated gonadotropin release in normal cycling women and patients with hyperprolactinemic amenorrhea.
Nicoletti I; Ambrosi F; Giammartino C; Fedeli L; Mannarelli C; Filipponi P
Horm Metab Res; 1986 Jul; 18(7):479-84. PubMed ID: 3091473
[TBL] [Abstract][Full Text] [Related]
13. [Effects of bromocriptine on endocrine environment in the polycystic ovary syndrome].
Huang HJ; Ishimaru T; Yamabe T
Nihon Naibunpi Gakkai Zasshi; 1988 Apr; 64(4):265-78. PubMed ID: 3136040
[TBL] [Abstract][Full Text] [Related]
14. Catecholamines and pituitary function. I. Effects of catecholamine synthesis inhibition and subsequent catecholamine infusion on gonadotropin and prolactin serum levels in normal cycling women and in women with hyperprolactinemic amenorrhea.
Nicoletti I; Filipponi P; Sfrappini M; Fedeli L; Petrelli S; Gregorini G; Santeusanio F; Brunetti P
Horm Res; 1984; 19(3):158-70. PubMed ID: 6425187
[TBL] [Abstract][Full Text] [Related]
15. Bromocriptine increases plasma estradiol-17 beta concentration in amenorrhea patients with normal serum prolactin.
Seppälä M; Unnérus HA; Hirvonen E; Ranta T
J Clin Endocrinol Metab; 1976 Aug; 43(2):474-7. PubMed ID: 950375
[TBL] [Abstract][Full Text] [Related]
16. Elevation of plasma immunoreactive luteinizing hormone releasing hormone in hyperprolactinemic-amenorrheic women on bromocriptine therapy.
Elkind-Hirsch KE; Platia MP; Schiff I
J Reprod Med; 1987 Jan; 32(1):5-9. PubMed ID: 3550065
[TBL] [Abstract][Full Text] [Related]
17. Hyperprolactinemia in cases of infertility and amenorrhea.
Furuhjelm M; Rydner T; Carlström K
Acta Obstet Gynecol Scand; 1980; 59(2):137-41. PubMed ID: 6773290
[TBL] [Abstract][Full Text] [Related]
18. The roles of estradiol and progesterone in decreasing luteinizing hormone pulse frequency in the luteal phase of the menstrual cycle.
Nippoldt TB; Reame NE; Kelch RP; Marshall JC
J Clin Endocrinol Metab; 1989 Jul; 69(1):67-76. PubMed ID: 2499593
[TBL] [Abstract][Full Text] [Related]
19. Altered neuroendocrine regulation of gonadotropin secretion in women distance runners.
Veldhuis JD; Evans WS; Demers LM; Thorner MO; Wakat D; Rogol AD
J Clin Endocrinol Metab; 1985 Sep; 61(3):557-63. PubMed ID: 3926810
[TBL] [Abstract][Full Text] [Related]
20. Reduction of gonadotropin-releasing hormone pulse frequency is associated with subsequent selective follicle-stimulating hormone secretion in women with polycystic ovarian disease.
Christman GM; Randolph JF; Kelch RP; Marshall JC
J Clin Endocrinol Metab; 1991 Jun; 72(6):1278-85. PubMed ID: 1902845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
